A phase II study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study)

Shoichi Hazama
Yusuke Nakamura
Hiroaki Tanaka
Kosei Hirakawa
Ko Tahara
Ryoichi Shimizu
Hiroaki Ozasa
Ryuichi Etoh
Fumiaki Sugiura
Kiyotaka Okuno
Takumi Furuya
Taku Nishimura
Koichiro Sakata
Kazuhiko Yoshimatsu
Hiroko Takenouchi
Ryouichi Tsunedomi
Yuka Inoue
Shinsuke Kanekiyo
Yoshitaro Shindo
Nobuaki Suzuki
Shigefumi Yoshino
Hirokazu Shinozaki
Akira Kamiya
Hiroyuki Furukawa
Takeharu Yamanaka
Tomonobu Fujita
Yutaka Kawakami
Masaaki Oka

Journal of Translational Medicine

12

108

108

10.1186/1479-5876-12-108

https://doi.org/10.1186/1479-5876-12-108
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000335527600001&DestApp=WOS_CPL